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doi:10.1016/j.jds.2012.01.007Abstract Background/purpose: To identify genetic expression patterns that can be used to
define an appropriate diagnostic algorithm of clinical use in periodontal disease.
Materials and methods: Total RNA was extracted from 13 samples corresponding to normal
human gingiva (NHG) and human gingiva affected by periodontal disease (PDHG). A compre-
hensive gene expression analysis was carried out by microarray analysis using Affymetrix
Human Genome U133 plus 2.0 oligonucleotide arrays.
Results: Sixty-six probe sets (genes and expressed sequence tags e EST) overexpressed in all
samples of one of the comparison groups, were used for the diagnostic algorithm. All samples,
includingan independent test sample,werecorrectlyclassifiedasnormalorperiodontally affected
using the diagnostic algorithm. In addition, 2596 genes/ESTwere upregulated and 1542 genes/EST
were downregulated in PDHG, with numerous gene functions impaired in PDHG, especially those
related to the immune response, cell-cell junctions, and extracellular matrix remodeling.
Conclusion: Our study revealsdifferential geneexpressionprofiles inNHGandPDHG.Theproposed
diagnosticalgorithmcouldhave clinical usefulness fordifferential diagnosis in periodontal disease.
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Gene expression in periodontal disease 49Introduction Materials and methodsThe periodontium consists of several tissues and structures
that support and invest the tooth, including the gingiva,
periodontal ligament, cementum, and alveolar bone.1 The
term, periodontal disease, commonly refers to an inflam-
matory disorder that affects the normal condition of the
periodontium and might cause loss of supporting connective
tissue and alveolar bone. In this context, this disease
results in the formation of periodontal pockets, or deep-
ened crevices, between the gingiva and tooth root, and
severe periodontal disease can result in occasional pain and
discomfort, impaired mastication, and irreversible tooth
loss.2 The main causes of periodontal disease are associ-
ated with the presence of dental plaque microorganisms,
although several environmental insults, genetic disorders,
and systemic diseases can play important roles.
The global prevalence of severe periodontal disease
ranges from 10%w15%, although up to 90% may be affected
by some forms of periodontal disease.3 In addition to age
and race, other known risk factors for periodontal disease
include the body mass index,4 stress, tobacco, diabetes,
and nutrition.5,6 Furthermore, limited research on the
genetic component of adult periodontitis suggests that
approximately one-half of cases may be heritable.7
Clinical manifestations of periodontal disease are
multiple, ranging from mild bleeding of chronic gingivitis
produced during simple tooth brushing, to aggressive
periodontitis with tooth loss.3 In this milieu, the existing
clinical diagnosis of periodontal disease is based on visual,
clinical, and radiographic assessments of periodontal
tissues, rendering the diagnostic algorithm something
difficult and imprecise to determine.
Numerous diagnostic algorithms were proposed, based
on a clinical periodontal examination of the patient and
complementary radiographic and medical laboratory tests.
However, all these diagnostic approaches are subjective
and highly dependent on the operator.
Several studies suggested an important genetic influence
in periodontal disease. Although specific genetic markers
were identified in uncommon juvenile forms of perio-
dontitis, previous studies of specific genetic markers in
adults with periodontitis were not encouraging, and
knowledge of the pathogenesis and genes implicated in
periodontal disease is still deficient.8
Within this framework, microarray techniques were
proposed as a new diagnostic tool that could detect the
presence of active disease, predict future disease progres-
sion, and evaluate the response to periodontal therapy,
thereby improving the clinical management of periodontal
patients. Using these methods, several authors previously
determined the global gene expression profiles of several
types of human cancer9e11 and other multifactorial
diseases12,13 including periodontal disease.14,15 Nonethe-
less, genes involved in different biologic processes form
complex interaction networks,16 and several studies are
necessary to determine the exact roles of these genes in
periodontal disease.
The present study focused on identifying genetic expres-
sion patterns that can be used to define an appropriate
diagnostic algorithm of clinical use in aggressive periodontal
disease.Tissue samples
To determine the global gene expression profile of normal
human gingiva (NHG) and human gingiva affected by peri-
odontal disease (PDHG), samples (six of NHG and seven of
PDHG) were obtained. The average age of NHG donor
patients was 44.6 years, and of patients with periodontal
disease was 42.6 years. All samples corresponded to biop-
sies of 2 2 2 mm from patients undergoing minor oral
surgical procedures under local anesthesia. NHG samples
were obtained from patients without inflammation or
gingival bleeding and normal periodontal attachment,
during teeth extraction for orthodontic reasons, or crown
enlargement for prosthetic reasons. PDHG samples were
extracted from patients with clinical gingival inflammation,
bleeding on probing, and periodontal attachment loss of >
4 mm clinically and radiologically diagnosed as aggressive
periodontitis. In both cases, biopsy samples corresponded
to gingival papillae that adhered to the root surface of the
extracted tooth, or crown enlargement (NHG) or from the
periodontally affected teeth (PDHG) during surgical peri-
odontal therapy with a mucoperiosteal flap.
All patients provided informed consent for the use of
donated tissues in this work. This study was approved by the
local Research and Ethics Committees of the University of
Granada. Experiments were undertaken with the under-
standing andwrittenconsent of each subject andaccording to
ethical principles, including the World Medical Association,
DeclarationofHelsinki, andadditional requirementsof Spain.
Comprehensive gene expression analysis by
a microarray
Once a tissue biopsy was obtained, samples were immedi-
ately immersed in 5 volumes of RNAlater (Ambion Applied
Biosystems, Austin, TX, USA) at e20C, to prevent RNA
degradation. Subsequently, RNAlater was removed, and
whole samples were sectioned into small pieces and dis-
rupted using a tissue blender homogenizer (IKA T10 basic
ULTRA-TURRAX, Staufen, Germany) in the presence of lysis
buffer. Total RNA corresponding to both types of samples
was extracted using the Qiagen RNeasy System (Qiagen,
Mississauga, Ontario, Canada), following the manufac-
turer’s recommendations. Total complementary (c)DNA was
synthesized using a T7-polyT primer and reverse tran-
scriptase (Superscript II, Life Technologies, Carlsbad, CA,
USA), and labeled cRNA was synthesized by in vitro tran-
scription with biotinylated UTP and CTP (Enzo Diagnostics,
Farmingdale, NY, USA). The labeled cRNA was hybridized
using Human Genome U133 plus 2.0 oligonucleotide arrays
(Affymetrix, Santa Clara, CA, USA), and absolute expression
values were calculated and normalized from the scanned
array using Affymetrix Microarray software.
Analysis of the microarray expression data
To identify all probe sets (genes and expressed sequence
tags - EST), the expressions of which were markedly higher
in one of the two groups of samples (NHG or PDHG)
Table 1 Genes/EST included in the diagnostic algorithm whose expression was higher (upregulated) or lower (downregulated)
in all PDHG samples as compared to NHG. Uniqid: Affymetrix Human Genome U133 Plus 2.0 reference of this specific gene/EST.
Mean expression data correspond to average expression for the group of NHG or PDHG expressed as Affymetrix fluorescent units
(f.u.). FCZ fold-change relative expression of the group of PDHG versus the group of NHG; NHGZ normal human gingival;
PDHGZ human gingival affected by periodontal disease. P value corresponds to the significance level of the Student t test for
the comparison of PDHG versus NHG.










Downregulated 230443_at NHP2L1 20.25 3.03 0.15 0.018 NHP2 non-histone chromosome protein
2-like 1 (S. cerevisiae)
Downregulated 1556147_at d 12.45 2.1 0.17 0.002 CDNA clone IMAGE:5274427
Downregulated 219612_s_at FGG 8.42 1.62 0.19 0.011 Fibrinogen gamma chain
Downregulated 235426_at GATM 15.97 3.02 0.19 0.01 Glycine amidinotransferase
(L-arginine:glycine amidinotransferase)
Downregulated 234448_at d 7.45 1.53 0.21 0.002 MRNA; cDNA DKFZp434F1872 (from clone
DKFZp434F1872)
Downregulated 236903_at d 10.27 2.28 0.22 0.004 Transcribed locus
Downregulated 1560842_a_at d 8.68 2.97 0.34 0.003 CDNA FLJ35846 fis, clone TESTI2006877
Downregulated 211196_at DBT 8.1 2.93 0.36 0.00042 Dihydrolipoamide branched chain
transacylase E2
Downregulated 230644_at LRFN5 10.73 4.07 0.38 0.002 Leucine rich repeat and fibronectin type
III domain containing 5
Downregulated 232423_at ARSD 63.38 24.7 0.39 0.009 Arylsulfatase D
Downregulated 230948_at d 30.22 16 0.53 0.002 CDNA FLJ42198 fis, clone THYMU2034338
Downregulated 219796_s_at MUPCDH 2.22 1.18 0.53 0.001 Mucin-like protocadherin
Downregulated 230585_at d 101.77 56.5 0.56 0.005 Transcribed locus
Downregulated 231725_at PCDHB2 53.58 29.97 0.56 0.009 Protocadherin beta 2
Downregulated 239863_at d 48.02 27.3 0.57 0.001 CDNA FLJ43322 fis, clone NT2RI2027975
Downregulated 210202_s_at BIN1 41.85 23.75 0.57 0.002 Bridging integrator 1
Downregulated 1554068_s_at FLJ32549 34.07 19.35 0.57 0.022 Hypothetical protein FLJ32549
Downregulated 238518_x_at GLYCTK 33.12 18.98 0.57 0.008 Glycerate kinase
Downregulated 202789_at PLCG1 116.63 67.9 0.58 0.004 Phospholipase C, gamma 1
Downregulated 1556111_s_at d 26.82 15.95 0.59 0.051 CDNA FLJ39819 fis, clone SPLEN2010534
Downregulated 244293_at UQCRB 26.73 15.78 0.59 0.001 Ubiquinol-cytochrome c reductase
binding protein
Downregulated 232662_x_at C10orf58 441.43 270.6 0.61 0.001 Chromosome 10 open reading frame 58
Downregulated 226719_at d 87.03 57.6 0.66 0.002 CDNA FLJ34899 fis, clone NT2NE2018594
Downregulated 220553_s_at PRPF39 195.18 132.33 0.68 0.011 PRP39 pre-mRNA processing factor 39
homolog (S. cerevisiae)
Downregulated 239538_at ZRANB3 40.37 27.52 0.68 0.005 zinc finger, RAN-binding domain
containing 3
Downregulated 224747_at UBE2Q2 967.83 666.13 0.69 0.012 Ubiquitin-conjugating enzyme E2Q
(putative) 2
Downregulated 213573_at d 193.12 139.87 0.72 0.006 Transcribed locus
Downregulated 239376_at d 75.75 56.92 0.75 0.004 CDNA clone IMAGE:4333081
Downregulated 207121_s_at MAPK6 2951.82 2312.5 0.78 0.006 Mitogen-activated protein kinase 6
Downregulated 214672_at TTLL5 144.03 125.35 0.87 0.014 Tubulin tyrosine ligase-like family,
member 5
Upregulated 203380_x_at SFRS5 949.47 1264.72 1.33 0.005 Splicing factor, arginine/serine-rich 5
Upregulated 225715_at KIAA1303 47.58 68.47 1.44 0.016 Raptor
Upregulated 223554_s_at RANGRF 17.1 30.67 1.79 0.006 RAN guanine nucleotide release factor
Upregulated 201340_s_at ENC1 16.4 29.5 1.8 0.002 Ectodermal-neural cortex (with BTB-like
domain)
Upregulated 243240_at d 13.88 25.72 1.85 0.00029 Transcribed locus
Upregulated 228804_at DGCR5 12.17 24.27 1.99 0.00215 DiGeorge syndrome critical region gene 5
(non-coding)
Upregulated 232497_at ZNF3 5.57 11.35 2.04 0.016 Zinc finger protein 3
Upregulated 204535_s_at REST 6.27 14.42 2.3 0.017 RE1-silencing transcription factor
Upregulated 241054_at d 7.37 19.17 2.6 0.001 Transcribed locus
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NHG P Gene title
Upregulated 217143_s_at TRA@ ///
TRD@
20.08 53.68 2.67 0.012 T cell receptor alpha locus ///T cell
receptor delta locus
Upregulated 1563341_at d 5.93 15.98 2.69 0.005 CDNA clone IMAGE:4831161
Upregulated 1557816_a_at d 3.7 10.68 2.89 0.029 Homo sapiens, clone IMAGE:3453782,
mRNA
Upregulated 244238_at d 5.97 18.57 3.11 0.017 Transcribed locus, moderately similar to
XP_001137143.1
Upregulated 1560550_at d 13.18 41.75 3.17 0.00022 Homo sapiens, clone IMAGE:5180210,
mRNA
Upregulated 243864_at CCDC80 4.03 13.6 3.37 0.001 Coiled-coil domain containing 80
Upregulated 233971_at LOC401565 4.45 15.03 3.38 0.001 Similar to 4931415M17 protein
Upregulated 241853_at d 2.3 8.05 3.5 0.038 Transcribed locus
Upregulated 244036_at d 3.22 11.47 3.56 0.037 Transcribed locus
Upregulated 213955_at MYOZ3 2.98 10.65 3.57 0.018 Myozenin 3
Upregulated 238429_at TMEM71 6.73 25.02 3.72 0.00023 Transmembrane protein 71
Upregulated 229179_at RUFY1 1.68 6.82 4.05 0.015 RUN and FYVE domain containing 1
Upregulated 237220_at d 1.52 6.23 4.11 0.069 Transcribed locus
Upregulated 240065_at FAM81B 2.22 9.18 4.14 0.002 Family with sequence similarity 81,
member B
Upregulated 1554886_a_at MLXIP 2.53 10.75 4.24 0.032 MLX interacting protein
Upregulated 1560943_s_at d 4.1 18.67 4.55 0.007 d
Upregulated 220565_at CCR10 2.87 13.38 4.67 0.011 Chemokine (C-C motif) receptor 10
Upregulated 213965_s_at CHD5 2.45 13.03 5.32 0.047 Chromodomain helicase DNA binding
protein 5
Upregulated 216096_s_at NRXN1 2.07 11.12 5.38 0.036 Neurexin 1
Upregulated 231287_s_at Klkbl4 2.22 11.98 5.41 0.064 Plasma kallikrein-like protein 4
Upregulated 210013_at HPX 3.87 21.98 5.69 0.048 Hemopexin
Upregulated 243836_at KIAA1843 0.75 4.3 5.73 0.075 KIAA1843 protein
Upregulated 1564134_at d 1.77 11.15 6.31 0.017 Transcribed locus
Upregulated 1556564_at HHIPL1 2.28 15.78 6.91 0.006 HHIP-like 1
Upregulated 232629_at PROK2 4.42 35.08 7.94 0.055 Prokineticin 2
Upregulated 207327_at EYA4 1.53 12.33 8.04 0.001 Eyes absent homolog 4 (Drosophila)
Upregulated 222202_at LOC644213 0.78 9.08 11.6 0.020 Similar to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)
Gene expression in periodontal disease 51compared to the other group, we first calculated the
average expression of each gene/EST in each sample group
(NHG and PDHG) using six samples of each type. Then, the
relative multiple of change in the expression of PDHG
versus NHG samples was calculated, and all genes/EST
with a relative multiple change in expression of > 2 were
selected as being overexpressed in PDHG. Genes with
a change in the relative multiple of expression of < 0.5
were selected as being downregulated in PDHG. A Gene
Ontology (GO) analysis of the selected genes/EST was
performed using BiNGO (http://www.psb.ugent.be/cbd/
papers/BiNGO/), a plug-in for the program Cytoscape.17
The set of selected genes was tested for enrichment
of any GO category relating to “biological processes”
compared to all annotated genes represented on the array.
Scores were evaluated based on the hypergeometric
distribution and Bonferroni correction for multiple testing.
Thus, the P value reflects the likelihood that one observed
such enrichment by chance alone.18To develop a periodontal disease diagnostic algorithm,
we identified and selected all genes/EST with absolute
expression levels higher for each of the six samples of one
group (NHG or PDHG) than for each of the six samples of the
other group. No exceptions were allowed. Average values of
each of these selected genes were statistically compared
using Student t test. Values of P< 0.05 were considered
statistically significant for two-tailed comparisons.
Hierarchical clustering was performed on the 12 samples
used to develop the classification algorithm using Cluster
and Tree-View software (Stanford University, Palo Alto,
CA, USA). Datasets used for hierarchical clustering were
normalized by standardizing each expression level of each
gene/EST and each sample to a mean of 0 and variance of 1.
To validate the algorithm, the 12 samples were clustered
along with an independent sample corresponding to a PDHG
biopsy. All cluster analyses were performed in a blinded
manner; that is, the sample type corresponding to each
sample was decoded only at the end of the process.
Figure 1 Proposed diagnostic algorithm for periodontal research. (A) Dendrogram representing cluster analysis of the 12 samples
used for developing the diagnostic algorithm; (B) cluster analysis of the 12 samples and 1 additional test PDHG sample used to
validate the algorithm. Genes with high relative expression are shown in red and genes with expression below the average are
shown in green. CTRZ control NHG samples; PERIODZ PDHG samples; Test sampleZ periodontally affected sample used to
validate the algorithm.
52 I. Garzo´n et alProtein expression by Western blotting
Whole-protein extracts of samples corresponding to NHG
and PDHG were obtained at the same experimental time of
messenger (m)RNA isolation using the Qiagen RNeasy System
(Qiagen). To perform this, 70% ethanol was added to cell
lysates and placed on an RNeasy mini column. All of the
flow-through was collected to obtain whole proteins from
the samples following the manufacturer’s instructions.
Therefore, 20 mL of each protein extract was loaded on
NuPAGE Novex 10% Bis-Tris gels (ref. NP0301, Invitrogen,
Carlsbad, CA, USA), separated by electrophoresis, and
transferred to nitrocellulose membranes following standard
procedures. Membranes were then blocked for 1 hour with
5% skimmed milk, before overnight incubation with the
following primary antibodies: rabbit anti-arylsulfatase D
(ARSD) (1:250, Sigma-Aldrich ref. HPA004694, St. Louis,
MO, USA), mouse anti-MAPK6 (1:200, Sigma-Aldrich ref.
WH0005597M1), andmouse anti-GAPDH (1:300, Calbiochem-
Merck ref. CB1001, KGaA, Darmstadt, Germany). Anti-ARSD
and anti-MAPK6 antibodies were selected from the list of
significant genes found by the microarray analysis, among
all genes with significant differences between NHG and
PDHG for which an antibody was commercially available.
Primary antibodies were detected using a horseradish
peroxidase-linked anti-mouse immunoglobulin G (IgG)
(Sigma-Aldrich ref. A9044) or anti-rabbit IgG (Sigma-Aldrich
ref. A0545). Visualization was performed using the ECL
Western Blotting Detection Reagent (GE Healthcare,
Waukesha, WI, USA). Blots were exposed to autoradiography
Kodak Biomax XAR films (Rochester, NY, USA).Results
Development of a diagnostic algorithm for
periodontal disease
The statistical analysis of all genes analyzed by the micro-
array analysis showed that expressions of 66 genes/EST
were significantly higher in all samples of a specific group
(NHG or PDHG). Indeed, 30 genes/EST were more highly
expressed in all NHG samples, whereas 36 genes/EST were
more highly expressed in all PDHG samples [P< 0.001
(Table 1)]. Of the 30 genes/EST downregulated in PDHG,
one-third of the genes/EST were expressed by at least
a 2-fold greater extent in control NHG than in diseased
samples. By contrast, 83.3% of the selected genes were
upregulated by at least 2-fold in PDHG compared to NHG.
The analysis of those 66 genes/EST revealed that the
functions of the genes/EST upregulated in the two groups
were partially similar. However, two genes with an impor-
tant role in the activation and regulation of the immune
response [the T cell receptor alpha and delta locus (TRAa
and TRDa), and the chemokine C-C motif receptor 10;
CCR10] were only upregulated in PDHG samples, whereas
a gene related to physiological extracellular matrix (ECM)
remodeling (ARSD) and a gene with a function in tissue
regeneration (L-arginine-glycine amidinotransferase; GATM)
were overexpressed only in control NHG.
When all 66 genes/EST selected were used to classify
samples analyzed in this work, we found that all 12 samples
were correctly clustered, with the six normal samples
clustered in one of the main branches of the tree and the
Table 2 Analysis of Gene-Ontology gene functions of
genes significantly upregulated in NHG and in PDHG using
Cytoscape-BiNGO. GO-IDZGene-Ontology reference for
the specific function. P-valueZ statistical significance
value for the hypergeometric distribution. The group of
samples (NHG or PDHG) in which each significant function
was overrepresented is shown in the last column of the
table.
GO-ID P Gene functions Upregulated
in
7275 0.004 Development NHG
16020 0.039 Membrane NHG
5886 0.00010 Plasma membrane NHG
44459 0.018 Plasma membrane part NHG
3823 0.005 Antigen binding PDHG
7155 0.00001 Cell adhesion PDHG
7154 0.00000 Cell communication PDHG
7267 0.022 Cell-cell signaling PDHG
5575 0.00002 Cellular component PDHG
6952 0.00000 Defense response PDHG
7275 0.00005 Development PDHG
31012 0.006 Extracellular matrix PDHG
5201 0.008 Extracellular matrix
structural constituent
PDHG
5576 0.00000 Extracellular region PDHG
6959 0.017 Humoral immune response PDHG
6955 0.00000 Immune response PDHG
16021 0.00000 Integral to membrane PDHG
5887 0.00012 Integral to plasma membrane PDHG
31224 0.00000 Intrinsic to membrane PDHG
31226 0.00010 Intrinsic to plasma membrane PDHG
16020 0.00000 Membrane PDHG
44425 0.00000 Membrane part PDHG
50874 0.00000 Organismal physiological
process
PDHG
5886 0.00000 Plasma membrane PDHG
44459 0.00005 Plasma membrane part PDHG
4872 0.00000 Receptor activity PDHG
5102 0.006 Receptor binding PDHG
9607 0.00000 Response to biotic stimulus PDHG
9605 0.00002 Response to external stimulus PDHG
51707 0.00023 Response to other organism PDHG
9613 0.00013 Response to pest, pathogen
or parasite
PDHG
50896 0.00000 Response to stimulus PDHG
9611 0.006 Response to wounding PDHG
4871 0.00000 Signal transducer activity PDHG
7165 0.00003 Signal transduction PDHG
4888 0.00019 Transmembrane receptor
activity
PDHG
Gene expression in periodontal disease 53remaining samples in the other branch [Fig. 1(A)]. Strik-
ingly, validation of the classification algorithm using an
independent validation sample corresponding to a PDHG
sample showed that this test sample was properly clustered
in the group of periodontally affected tissues [Fig. 1(B)].
Identification of genes significantly overexpressed
by NHG and PDHG
The gene expression analysis of NHG and PDHG revealed
that 1542 genes/EST were downregulated in PDHG by at
least 2-fold, whereas 2596 genes/EST were upregulated in
PDHG compared to control NHG samples (Supplementary
Table S1). An analysis of gene functions of these selected
genes using Cytoscape-BiNGO showed a statistically signif-
icant enrichment of four gene functions in the NHG group,
with 32 gene functions significantly represented by PDHG
(Table 2). Among the four gene functions that were more
represented by NHG, three functions corresponded to the
synthesis of several structural cell constituents, and one
was related to cell and tissue development. By contrast,
functions overrepresented by PDHG samples included 10
functions related to the immune response or responses to
different stimuli, nine functions to structural cell compo-
nents, three functions to the ECM, seven functions to signal
transduction and cell physiology, one function to develop-
ment, and one function to cell-cell adhesion. Illustrative
gene function diagrams corresponding to NHG and PDHG are
given in Figs. 3 and 4, respectively.
Western blot analysis of relevant genes in NHG and
PDHG
As shown in Fig. 2, the Western blot analysis of NHG and
PDHG cell lysates demonstrated that MAPK6 protein
expression was higher in NHG than in PDHG, as was the case
for the microarray analysis. Similarly, the ARSD protein was
significantly overexpressed in NHG samples compared to
PDHG samples.
Discussion
Periodontal disease is a chronic, destructive condition
affecting a high percentage of the adult population, char-
acterized by a persistent oral bacterial infection which
replaces the normal microbiota.19 This may be due to
disequilibrium in the host, which can be caused by several
factors, such as genetic factors, modification of the envi-
ronmental conditions of the infected site, a significant
decrease in the proportion of beneficial bacteria producing
inhibitory substances, and/or decreased efficacy of the
host immune system.20,21 There is no doubt that genes play
an important role in the predisposition to and progression
of periodontal diseases.22
Although the disease is very prevalent and often
aggressive, diagnostic methods currently available for this
pathology are mainly subjective, and a firm, objective, and
observer-independent diagnostic algorithm has not been
established to date.23,24 Moreover, elucidating the manner
and extent to which genetic factors contribute to the originand progression of this disease, may have important
therapeutic implications. In this context, high-throughput,
genome-wide analytical technologies, especially expres-
sion microarrays, were shown to be both accurate and
precise when properly implemented.25 Expression micro-
arrays can be used for disease classification and identifi-
cation of causal mechanisms in different human
diseases,25 including multiple sclerosis,26 cancer,27 and
Figure 2 Western blot analysis of ARSD (arylsulfatase D) and
MAPK6 (mitogen-activated protein kinase 6) protein expression
in control NHG and two illustrative PDHG samples. Expression
of the housekeeping protein GAPDH was used as a control of
initial protein loading.
54 I. Garzo´n et aleven periodontal disease.14,28 However, a microarray-based
diagnostic algorithm had not been proposed to date.
In this work, we were able to identify a number of genes
and gene functions, the expressions of which were altered
in PDHG compared to NHG. In the first place, our
gene-function analysis demonstrated that numerous gene
functions related to the synthesis of some structural
components and cell physiological processes were signifi-
cantly altered in PDHG. These results suggest that exten-
sive alteration of cell functions takes place in tissues
affected by aggressive periodontal disease. Furthermore,Figure 3 Significant results from the Gene-Ontology analysis of
within their hierarchical tree of the Gene-Ontology classification s
Starting from the most general category, genes are classified stepw
as daughter branches. Branches that were not enriched in our analy
category is represented by the node size and the statistical enrichm
genes is represented as pseudocolor (red for highly enriched, orang
white for non-enriched).our analysis revealed downregulation of genes with a role in
maintaining a structural cell membrane barrier in PDHG
compared to control NHG.
In the second place, our gene-expression analysis
revealed that a high number of genes associated with
the immune response were impaired in PDHG samples,
including the TRAa and CCR10 genes. The TRAa/TRDa
is expressed on the surface of T lymphocytes and is
responsible for recognizing antigens bound to the major
histocompatibility complex (MHC). This gene was also
demonstrated to be an essential mediator of alveolar bone
destruction in rapidly progressing cases.29 This could
explain why periodontal disease is characterized by alve-
olar bone loss and immune-system activation. On the other
hand, chemokine receptors such as CCR10 may play
a fundamental role in activating the immune system, cell
trafficking of various types of leukocytes, homeostasis, and
angiogenesis. In this milieu, gums and pocket bleeding,
early signs of the periodontal disease, could be predicted
early by chemokine upregulation tests designed as
a microarray. In addition, much research suggested that
bacterial colonization may lead to an altered environment,
where overexpression of TRAa is stimulated by inflamma-
tory cytokines such as CCR10 in response to infection.30
Additionally, it is well known that cell-cell junctions can
be altered in periodontal disease by bacterial colonization
and protease activity mainly caused by Porphyromonas
gingivalis, which is able to degrade several kinds of
epithelial junctional proteins.31,32 Our microarray analysis
confirmed this cell-cell junction alteration in PDHG, withgenes upregulated in NHG using Cytoscape-BiNGO are shown
ystem. Each node represents a single Gene-Ontology category.
ise into smaller and more specific categories, which are shown
sis are not shown. The number of genes in each Gene-Ontology
ent (P value from a hypergeometric distribution test) of these
e for significantly enriched, yellow for potentially enriched and
Figure 4 Significant results from the Gene-Ontology analysis of genes upregulated in PDHG using Cytoscape-BiNGO are shown
within their hierarchical tree of the Gene-Ontology classification system. Each node represents a single Gene-Ontology category.
Starting from the most general category, genes are classified stepwise into smaller and more specific categories, which are shown
as daughter branches. Branches that were not enriched in our analysis are not shown. The number of genes in each Gene-Ontology
category is represented by the node size and the statistical enrichment (P value from a hypergeometric distribution test) of these
genes is represented as pseudocolor (red for highly enriched, orange for significantly enriched, yellow for potentially enriched and
white for non-enriched).
Gene expression in periodontal disease 55significant changes in the expressions of cadherins (CDH2,
CDH7, and CDH16), junctophilins (JPH2 and JPH3), and
a tight junction protein (TJP3). All of these junction
proteins are characterized by their relevant contributions
to stabilization of intercellular junctions, and any modifi-
cation of their functions may alter the crucial barrier
function of the oral-mucosa epithelium.33
Finally, altered expressions of genes related to the
synthesis and remodeling of the ECM such as ARSD, several
types of collagens (COL4A6, COL11A1, COL14A1, COL24A1,
COL25A1, and COL9A1), and type III fibronectin (FSD1L) in
PDHG suggest that the capacity of PDHG tissues to remodel
and repair components of the ECM is impaired in this disease.
Although this study has several limitations, including the
low number of samples analyzed, the possibility of false
negatives or false positives, and the limited value of
genetic patterns as predictors of periodontal disease per
se, from the results of this study, we proposed a preliminary
diagnostic algorithm based on the microarray-determined
gene expressions of a reduced number of relevant genes/
EST. Using this algorithm, it was possible to properly
classify the 12 samples used to develop the algorithm,
and also to correctly diagnose an independent samplecorresponding to diseased PDHG. Although some previous
studies significantly contributed to a better understanding
of the pathobiology of this disease,14,28 this is the first time
that an algorithm based on a microarray gene-expression
analysis allows for an observer-independent diagnosis of
human periodontal disease. Using this novel technique will
contribute to a better understanding of the genetic mech-
anisms that are involved in the genesis and progression of
human aggressive periodontal disease, and also will allow
the accurate classification of a patient as normal or peri-
odontally affected in a completely objective way. This will
be especially useful in cases in which clinical signs and
symptoms are not clear, in order to establish appropriate
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